Consensus development conference on the use of nonsteroidal anti-inflammatory agents, including cyclooxygenase-2 enzyme inhibitors and aspirin
about
Acupuncture for peripheral joint osteoarthritisImpact of EHR-based clinical decision support on adherence to guidelines for patients on NSAIDs: a randomized controlled trialAspirin and proton pump inhibitor combination therapy for prevention of cardiovascular disease and Barrett's esophagus.Safe prescribing of non-steroidal anti-inflammatory drugs in patients with osteoarthritis--an expert consensus addressing benefits as well as gastrointestinal and cardiovascular risksDouble-blind randomized trials of single-tablet ibuprofen/high-dose famotidine vs. ibuprofen alone for reduction of gastric and duodenal ulcersTopical nonsteroidal anti-inflammatory drugs for the treatment of pain due to soft tissue injury: diclofenac epolamine topical patch.Intraplantar-injected ceramide in rats induces hyperalgesia through an NF-κB- and p38 kinase-dependent cyclooxygenase 2/prostaglandin E2 pathway.DUEXIS(®) (ibuprofen 800 mg, famotidine 26.6 mg): a new approach to gastroprotection for patients with chronic pain and inflammation who require treatment with a nonsteroidal anti-inflammatory drug.Of timing and surrogates: a way forward for cancer chemoprevention.Use of proton pump inhibitors and risk of osteoporosis-related fractures.Management of chronic nonmalignant pain with nonsteroidal antiinflammatory drugs. Joint opinion statement of the Ambulatory Care, Cardiology, and Pain and Palliative Care Practice and Research Networks of the American College of Clinical Pharmacy.Treatment and chemoprevention of NSAID-associated gastrointestinal complications.Education-based approach to addressing non-evidence-based practice in preventing NSAID-associated gastrointestinal complications.Safety aspects and rational use of a naproxen + esomeprazole combination in the treatment of rheumatoid disease.The Inappropriate Prescription of Oral Proton Pump Inhibitors in the Hospital Setting: A Prospective Cross-Sectional Study.Upper gastrointestinal bleeding in hospital inpatients: the role of antithrombotic drugs.Gastro-protective policy and the incidence of upper gastrointestinal bleeding.Gastroprotective efficacy and safety of single-tablet ibuprofen/famotidine vs ibuprofen in older persons.Prevention and Treatment of NSAID Gastropathy.Falling mortality when adjusted for comorbidity in upper gastrointestinal bleeding: relevance of multi-disciplinary care.Aspirin and the Primary Prevention of Cardiovascular Diseases: An Approach Based on Individualized, Integrated Estimation of Risk.Occult vs. overt upper gastrointestinal bleeding - inverse relationship and the use of mucosal damaging and protective drugs.Using Single-Item Health Literacy Screening Questions to Identify Patients Who Read Written Nonsteroidal Anti-Inflammatory Medicine Information Provided at Pharmacies
P2860
Q24240288-EE58B05C-5A96-40E6-B6B6-97F385CDA70AQ28385750-7902562A-C666-40DB-9416-0177EAC14532Q30457290-4DC6B6E4-9E70-4869-AA65-63A906B87876Q30629677-987F7605-22F0-428F-90A6-5AE9D0305735Q34241978-1878BE97-E436-4690-9E01-D7C11E4DF930Q34418290-D8B3375D-4AAD-40EA-9228-D92C4DEC0EBCQ35105360-C6CA9C73-85A3-4F41-AF1D-EAB47798CB27Q36280849-5A40E383-CAE7-4B5C-A772-04D1AACACCA0Q36616627-C4E10E93-E387-4F56-84A6-071A485B20EDQ36803505-63B57269-4CC4-4F9E-AB18-69C903049AD4Q37173212-DF6C5EEC-338F-4FD6-B917-2616D644EFB8Q37230285-83BF9C69-B1EB-4635-9883-04D3B3061D99Q37481108-8516D45A-52EF-4CD8-BC19-C995B16D4123Q37900840-94165260-38C6-41ED-8332-6B3AA3DB5174Q38404870-AEC1C037-5B70-4472-AC64-D4B55E43165BQ38420391-D49D49B2-7722-4161-9D97-4FAA64F792F9Q38609152-84F84C8D-8F7D-4405-AF34-FD33E7754C41Q40747378-A966DF9E-8B0C-4E54-87FB-A017B42EFDAFQ41744470-7818A91F-C76E-4D47-B84E-A5E1C4159E8FQ42293545-8AAE6C28-BE86-44F3-94A5-C83D002E402DQ48338773-76FD04D8-7E75-4ED6-A7A4-4BB31DDC5026Q53493512-D455C79C-7BEC-4550-AD81-63D69BC8EF8AQ58973640-1B186CD6-F687-4EB2-BFD3-1051E9CFC62E
P2860
Consensus development conference on the use of nonsteroidal anti-inflammatory agents, including cyclooxygenase-2 enzyme inhibitors and aspirin
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Consensus development conferen ...... enzyme inhibitors and aspirin
@ast
Consensus development conferen ...... enzyme inhibitors and aspirin
@en
Consensus development conferen ...... enzyme inhibitors and aspirin
@nl
type
label
Consensus development conferen ...... enzyme inhibitors and aspirin
@ast
Consensus development conferen ...... enzyme inhibitors and aspirin
@en
Consensus development conferen ...... enzyme inhibitors and aspirin
@nl
prefLabel
Consensus development conferen ...... enzyme inhibitors and aspirin
@ast
Consensus development conferen ...... enzyme inhibitors and aspirin
@en
Consensus development conferen ...... enzyme inhibitors and aspirin
@nl
P2093
P50
P1476
Consensus development conferen ...... enzyme inhibitors and aspirin
@en
P2093
Angel Lanas
Byron Cryer
C Mel Wilcox
Carol Regueiro
Harold Paulus
Keith Benzuly
Marie Borum
Richard Hunt
Uri Ladabaum
P304
P356
10.1016/J.CGH.2006.04.010
P407
P577
2006-09-01T00:00:00Z